SARS-CoV-2 Spike (RBD domain) Recombinant Antigen

Alternative antigen recommendations are AGX821, AGX823, or AGX824

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

COVID-19 Spike (RBD domain) Recombinant Antigen expressed in CHO cells, Cat. No. AGX822 is for use in Lateral Flow Assay and ELISA.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

fragment

Purified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.